title: Spatial analysis of advanced-stage ovarian cancer mortality in California.
abstract: OBJECTIVE
  We sought to determine the impact of geographic location on advanced-stage ovarian cancer mortality in relation to adherence to National Comprehensive Cancer Network (NCCN) treatment guidelines and hospital case volume.
  
  
  METHODS
  This was a retrospective observational cohort study of patients diagnosed with stage IIIC/IV epithelial ovarian cancer (Jan. 1, 1996, through Dec. 31, 2006) identified from the California Cancer Registry. Generalized additive models were created to assess the effect of spatial distributions of geographic location, demographic characteristics, disease-related variables, adherence to NCCN guidelines, and hospital case volume, with simultaneous smoothing of geographic location and adjustment for confounding variables.
  
  
  RESULTS
  A total of 11,765 patients were identified. Twelve of the 378 hospitals (3.2%) were high-volume hospitals (HVH) (≥20 cases/y) and cared for 2112 patients (17.9%). For all patients, the median distance to an HVH was 22.7 km/14.1 miles and 80% were located within 79.6 km/49.5 miles of an HVH. Overall, 45.4% of patients were treated according to NCCN guidelines. The global test for location revealed that geographic position within the state was significantly correlated with ovarian cancer mortality after adjusting for other variables (P < .001). Distance to receive care ≥32 km/20 miles was protective against mortality (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.79-0.93), while distance from an HVH ≥80 km/50 miles was associated with an increased risk of death (HR, 1.13; 95% CI, 1.03-1.23). The effects of geographic predictors were attenuated when nonadherence to NCCN guidelines (HR, 1.25; 95% CI, 1.18-1.32) and care at an HVH (HR, 0.87; 95% CI, 0.81-0.93) were introduced into the model.
  
  
  CONCLUSIONS
  Geographic location is a significant predictor of advanced-stage ovarian cancer mortality and the effect is primarily related to the likelihood of receiving NCCN guideline adherent care and treatment at an HVH.
authors: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, Medical Center, Orange, CA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Medical Center, Orange, CA. Electronic address: rbristow@uci.edu.
authors: Robert E
authors: RE
authors: Bristow
authors: Department of Epidemiology, University of California, Irvine, School of Medicine, Irvine, CA.
authors: Jenny
authors: J
authors: Chang
authors: Department of Epidemiology, University of California, Irvine, School of Medicine, Irvine, CA.
authors: Argyrios
authors: A
authors: Ziogas
authors: Chao Family Comprehensive Cancer Center, University of California, Irvine, Medical Center, Orange, CA; Department of Statistics, University of California, Irvine, School of Medicine, Irvine, CA.
authors: Daniel L
authors: DL
authors: Gillen
authors: Department of Statistics, University of California, Irvine, School of Medicine, Irvine, CA.
authors: Lu
authors: L
authors: Bai
authors: Department of Statistics, University of California, Irvine, School of Medicine, Irvine, CA; Program in Public Health, University of California, Irvine, School of Medicine, Irvine, CA.
authors: Veronica M
authors: VM
authors: Vieira
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002140:California / Q000453:epidemiology; D000077216:Carcinoma, Ovarian Epithelial; D005260:Female; D061847:Hospitals, High-Volume; D061846:Hospitals, Low-Volume; D006801:Humans; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000401:mortality*; D010051:Ovarian Neoplasms / Q000401:mortality*; D062206:Spatial Analysis; D055815:Young Adult
keywords: geographic location; ovarian cancer
references: Oncology (Williston Park). 1996 Nov;10(11 Suppl):293-310
references: 8953610
references: J Clin Oncol. 2005 Dec 20;23(36):9079-88
references: 16301598
references: Environ Health. 2005 Jun 14;4:11
references: 15955253
references: Cancer. 2010 Oct 15;116(20):4840-8
references: 20578182
references: Stat Methods Med Res. 1995 Sep;4(3):187-96
references: 8548102
references: Environ Health Perspect. 2010 Jul;118(7):957-61
references: 20338859
references: Cancer. 2007 May 15;109(10):2031-42
references: 17420977
references: Obstet Gynecol. 2013 Jun;121(6):1226-1234
references: 23812456
references: Gynecol Oncol. 2014 Feb;132(2):411-5
references: 24246773
references: Spat Spatiotemporal Epidemiol. 2011 Dec;2(4):291-300
references: 22748227
references: Am J Epidemiol. 2003 Mar 15;157(6):539-45
references: 12631544
references: Int J Health Geogr. 2006 Jun 09;5:26
references: 16764727
references: Gynecol Oncol. 2014 May;133(2):142-6
references: 24517876
references: Cancer. 2002 Mar 15;94(6):1886-93
references: 11920552
references: Gynecol Oncol. 2006 Nov;103(2):383-90
references: 17005244
references: Gynecol Oncol. 2010 Sep;118(3):262-7
references: 20573392
references: Cancer. 1997 Aug 15;80(4):816-26
references: 9264366
references: Health Serv Res. 2006 Dec;41(6):2201-18
references: 17116116
references: J Natl Cancer Inst. 2013 Jun 5;105(11):823-32
references: 23539755
references: Gynecol Oncol. 2014 Feb;132(2):403-10
references: 24361578
references: Gynecol Oncol. 2014 Jul;134(1):60-7
references: 24680770
references: Gynecol Oncol. 2011 Jul;122(1):100-6
references: 21496889
references: J Urban Health. 2012 Oct;89(5):828-47
references: 22566148
references: J Clin Oncol. 2003 Sep 15;21(18):3488-94
references: 12972525
references: Int J Gynecol Cancer. 2013 Feb;23(2):282-7
references: 23295939
references: Cancer Causes Control. 2001 Oct;12(8):703-11
references: 11562110
references: CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
references: 24399786
references: J Natl Compr Canc Netw. 2004 Nov;2(6):526-47
references: 19780297
references: Ulster Med J. 1991 Oct;60(2):137-49
references: 1785146
references: BMC Cancer. 2008 Sep 12;8:258
references: 18789142
references: Gynecol Oncol. 2012 Apr;125(1):19-24
references: 22108636
references: Gynecol Oncol. 2009 Dec;115(3):334-8
references: 19766295